Corporate News     18-Oct-16
Marksans Pharma gets ANDA approval for Paricalcitol Capsules
From USFDA
Marksans Pharma announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Paricalcitol Capsules 1mcg, 2 mcg and 4 mcg.

Paricalcitol Capsules 1mcg, 2 mcg and 4 mcg are therapeutically equivalent to the reference listed drug Zemplar Capsules 1 mcg, 2 mcg and 4 mcg of Abbvie Inc.

Previous News
  Marksans Pharma consolidated net profit declines 3.87% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:22 )
  Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
 ( Results - Announcements 13-Feb-23   14:08 )
  Marksans Pharma consolidated net profit declines 62.70% in the March 2022 quarter
 ( Results - Announcements 31-May-22   14:42 )
  Marksans Pharma standalone net profit declines 33.55% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:23 )
  Marksans Pharma to declare Quarterly Result
 ( Corporate News - 17-Jan-24   17:29 )
  Marksans Pharma acquires Dubai-based Access Healthcare for Rs 27 cr
 ( Hot Pursuit - 25-Apr-22   12:30 )
  Marksans Pharma announces UK MHRA nod for Bells Healthcare All in One Oral Solution
 ( Hot Pursuit - 22-Feb-22   15:15 )
  Marksans Pharma receives UK MHRA approval for Bells Healthcare All in One Oral Solution
 ( Corporate News - 22-Feb-22   14:05 )
  Marksans Pharma consolidated net profit rises 119.62% in the June 2020 quarter
 ( Results - Announcements 04-Aug-20   11:48 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 02-Jun-20   17:55 )
  Federal-Mogul Goetze (India) Ltd leads gainers in 'B' group
 ( Hot Pursuit - 17-Dec-19   12:15 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top